|Min SIP Amount||Not Supported|
|NAV||₹12.99 (20 Jan 2021)|
|Fund Started||27 Mar 2018|
|Fund Size||₹371 Cr|
|HDFC Bank Ltd.||Financial||Equity||11.1%|
|Divi's Laboratories Ltd.||Healthcare||Equity||6.9%|
|ICICI Bank Ltd.||Financial||Equity||6.6%|
|Dixon Technologies (India) Ltd.||Engineering||Equity||5.9%|
|State Bank of India||Financial||Equity||4.2%|
|Colgate-Palmolive (India) Ltd.||FMCG||Equity||4.0%|
|Tata Consultancy Services Ltd.||Technology||Equity||3.8%|
|Neogen Chemicals Ltd.||Chemicals||Equity||3.6%|
|Reliance Industries Ltd.||Energy||Equity||3.5%|
|Bharti Airtel Ltd.||Communication||Equity||3.1%|
SBI Long Term Advantage Fund Series V Direct Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 27 Mar 2018. R Srinivasan is the Current Fund Manager of SBI Long Term Advantage Fund Series V Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹371 Cr and the Latest NAV as of 20 Jan 2021 is ₹12.99.
The SBI Long Term Advantage Fund Series V Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit.
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.